— Know what they know.
Not Investment Advice

PBYI NASDAQ

Puma Biotechnology, Inc.
1W: -1.9% 1M: -5.1% 3M: +3.2% YTD: +22.2% 1Y: +94.2% 3Y: +146.5% 5Y: -31.2%
$7.08
+0.03 (+0.43%)
 
Weekly Expected Move ±4.4%
$6 $7 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 45 · $360.4M mcap · 39M float · 0.886% daily turnover · Short 57% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 40.3%
Cost Advantage ★
63
Intangibles
39
Switching Cost
52
Network Effect
33
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PBYI shows a Weak competitive edge (44.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 40.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 7Sell: 4Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
May 22, 2026
DCF
5
ROE
5
ROA
5
D/E
3
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PBYI receives an overall rating of A. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: P/E (2/5).
Rating Change History
DateFromTo
2026-05-18 A+ A
2026-05-08 A A+
2026-05-06 A+ A
2026-04-27 A A+
2026-04-01 A+ A
2026-03-24 A A+
2026-02-24 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

46 Grade A
Profitability
49
Balance Sheet
85
Earnings Quality
49
Growth
21
Value
62
Momentum
54
Safety
0
Cash Flow
93
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PBYI scores highest in Cash Flow (93/100) and lowest in Safety (0/100). An overall grade of A places PBYI among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.03
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.57
Unlikely Manipulator
Ohlson O-Score
-8.53
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB
Score: 56.8/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.20x
Accruals: -13.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PBYI scores -4.03, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PBYI scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PBYI's score of -2.57 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PBYI's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PBYI receives an estimated rating of BBB (score: 56.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PBYI's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
14.76x
PEG
-0.42x
P/S
1.59x
P/B
2.80x
P/FCF
6.06x
P/OCF
6.06x
EV/EBITDA
5.85x
EV/Revenue
1.13x
EV/EBIT
7.72x
EV/FCF
4.77x
Earnings Yield
7.51%
FCF Yield
16.50%
Shareholder Yield
0.00%
Graham Number
$5.26
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14.8x earnings, PBYI trades at a reasonable valuation. An earnings yield of 7.5% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $5.26 per share, 35% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.838
NI / EBT
×
Interest Burden
0.878
EBT / EBIT
×
EBIT Margin
0.146
EBIT / Rev
×
Asset Turnover
1.058
Rev / Assets
×
Equity Multiplier
1.931
Assets / Equity
=
ROE
21.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PBYI's ROE of 21.9% is driven by Asset Turnover (1.058), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
67.57%
Fair P/E
143.65x
Intrinsic Value
$68.89
Price/Value
0.09x
Margin of Safety
90.72%
Premium
-90.72%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PBYI's realized 67.6% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $68.89, PBYI appears undervalued with a 91% margin of safety. The adjusted fair P/E of 143.6x compares to the current market P/E of 14.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$7.08
Median 1Y
$4.06
5th Pctile
$1.03
95th Pctile
$16.03
Ann. Volatility
80.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alan H. Auerbach
President and Chief Executive Officer
$931,333 $551,549 $3,062,337
Jeff J. Ludwig
Chief Commercial Officer
$264,880 $132,998 $1,476,167
Maximo F. Nougues
Chief Financial Officer
$562,961 $170,848 $1,241,215
Douglas Hunt, B.Sc.
(Hons) Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer
$489,060 $133,765 $1,061,400

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,062,337
Avg Employee Cost (SGA/emp): $395,793
Employees: 179

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
179
+4.1% YoY
Revenue / Employee
$1,275,816
Rev: $228,371,000
Profit / Employee
$173,804
NI: $31,111,000
SGA / Employee
$395,793
Avg labor cost proxy
R&D / Employee
$346,749
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -6.1% -8.4% 6.9% 11.7% 8.2% -2.3% 0.0% 50.2% -25.5% 38.8% 57.5% 41.0% 23.2% 61.9% 41.6% 52.3% 66.6% 50.8% 28.0% 21.9% 21.92%
ROA -14.6% -20.1% -12.3% -20.8% -14.6% 4.2% 0.0% 2.1% -1.1% 1.7% 9.5% 6.8% 3.9% 10.3% 13.6% 17.2% 21.8% 16.7% 14.5% 11.4% 11.35%
ROIC -72.2% -60.6% -71.5% -1.2% -52.3% -29.7% 0.2% 47.1% 31.2% 41.4% 45.0% 35.0% 23.7% 44.2% 59.6% 68.0% 80.9% 61.5% 52.9% 40.3% 40.29%
ROCE -15.8% -26.4% -13.6% -31.3% -19.6% 18.2% 8.3% 12.2% 7.7% 11.8% 26.3% 21.7% 16.8% 28.3% 31.2% 36.9% 44.4% 33.3% 31.4% 24.5% 24.53%
Gross Margin 77.6% 77.8% 78.5% 76.3% 74.9% 78.1% 74.4% 75.0% 78.3% 76.3% 66.3% 75.5% 77.4% 63.9% 76.4% 77.1% 76.5% 77.7% 69.3% 76.7% 76.74%
Operating Margin -31.2% -19.4% -42.6% -1.6% 20.3% 4.2% 15.3% 8.3% 9.0% 15.3% 20.5% -5.3% -4.6% 27.4% 22.6% 8.7% 12.7% 17.6% 22.7% -8.5% -8.54%
Net Margin -9.6% -96.6% 7.6% -7.4% 15.7% -0.6% -8.5% 2.7% 3.9% 10.3% 17.0% -11.0% -9.6% 25.2% 32.7% 6.5% 11.2% 16.2% 17.8% -8.4% -8.37%
EBITDA Margin 2.6% -84.5% 17.0% 3.8% 24.5% 9.0% 0.3% 14.7% 15.6% 20.4% 25.4% 3.8% 4.5% 33.0% 30.0% 17.9% 20.5% 24.7% 27.7% -3.0% -2.96%
FCF Margin 0.6% 4.2% 8.2% -10.9% -17.3% -13.3% -10.0% -2.5% 4.9% 2.0% 6.1% 15.7% 15.2% 13.8% 16.9% 13.4% 18.6% 20.2% 18.3% 23.6% 23.59%
OCF Margin 4.6% 8.2% 8.2% -10.9% -17.3% -13.3% -6.9% 5.8% 13.4% 10.6% 11.5% 15.7% 15.2% 13.9% 16.9% 13.4% 18.6% 20.3% 18.3% 23.6% 23.60%
ROE 3Y Avg snapshot only 29.60%
ROA 3Y Avg snapshot only 11.93%
ROIC 3Y Avg snapshot only 34.51%
ROIC Economic snapshot only 16.02%
Cash ROA snapshot only 24.78%
Cash ROIC snapshot only 87.37%
CROIC snapshot only 87.35%
NOPAT Margin snapshot only 10.88%
Pretax Margin snapshot only 12.80%
R&D / Revenue snapshot only 29.93%
SGA / Revenue snapshot only 31.71%
SBC / Revenue snapshot only 3.00%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -10.61 -5.93 -4.30 -2.48 -3.75 10.98 96897.00 30.32 -68.31 33.83 9.63 16.61 18.05 5.40 4.98 3.88 3.55 7.31 9.85 13.32 14.763
P/S Ratio 1.46 1.14 0.49 0.61 0.62 0.50 0.85 0.62 0.72 0.55 0.88 1.13 0.72 0.51 0.65 0.63 0.72 1.28 1.34 1.43 1.586
P/B Ratio -62.44 -48.08 -51.01 -49.70 -52.85 -44.15 8.97 6.74 7.71 5.82 3.89 4.78 2.95 2.35 1.64 1.60 1.87 2.94 2.35 2.49 2.803
P/FCF 226.86 27.44 6.04 -5.55 -3.62 -3.73 -8.49 -25.17 14.73 27.09 14.48 7.20 4.73 3.72 3.88 4.74 3.89 6.31 7.35 6.06 6.062
P/OCF 31.84 13.99 6.04 10.63 5.40 5.19 7.70 7.17 4.72 3.71 3.87 4.72 3.88 6.29 7.33 6.06 6.061
EV/EBITDA -45.24 -13.64 -30.08 -5.89 -12.31 4.61 10.49 6.48 9.27 5.70 4.86 6.78 5.15 2.89 2.58 2.21 2.29 4.86 4.45 5.85 5.846
EV/Revenue 1.57 1.25 0.63 0.78 0.79 0.65 1.00 0.76 0.87 0.69 0.95 1.20 0.79 0.58 0.54 0.52 0.61 1.15 1.04 1.13 1.127
EV/EBIT -19.39 -9.15 -10.02 -4.26 -7.14 6.71 18.84 10.16 17.97 9.32 6.48 9.54 7.87 3.80 3.39 2.80 2.79 6.24 5.60 7.72 7.724
EV/FCF 243.69 30.08 7.71 -7.13 -4.59 -4.92 -9.94 -30.91 17.66 34.25 15.56 7.64 5.20 4.18 3.19 3.88 3.28 5.68 5.69 4.77 4.775
Earnings Yield -9.4% -16.9% -23.3% -40.3% -26.7% 9.1% 0.0% 3.3% -1.5% 3.0% 10.4% 6.0% 5.5% 18.5% 20.1% 25.8% 28.2% 13.7% 10.1% 7.5% 7.51%
FCF Yield 0.4% 3.6% 16.5% -18.0% -27.6% -26.8% -11.8% -4.0% 6.8% 3.7% 6.9% 13.9% 21.1% 26.9% 25.8% 21.1% 25.7% 15.9% 13.6% 16.5% 16.50%
Price/Tangible Book snapshot only 3.653
EV/OCF snapshot only 4.774
EV/Gross Profit snapshot only 1.513
Acquirers Multiple snapshot only 8.679
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $5.26
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.28 1.28 1.28 1.28 1.28 1.28 1.73 1.73 1.73 1.73 1.57 1.57 1.57 1.57 1.54 1.54 1.54 1.54 2.00 2.00 2.002
Quick Ratio 1.25 1.25 1.21 1.21 1.21 1.21 1.67 1.67 1.67 1.67 1.50 1.50 1.50 1.50 1.45 1.45 1.45 1.45 1.93 1.93 1.934
Debt/Equity -20.32 -20.32 -47.69 -47.69 -47.69 -47.69 5.29 5.29 5.29 5.29 2.09 2.09 2.09 2.09 0.80 0.80 0.80 0.80 0.22 0.22 0.219
Net Debt/Equity 1.54 1.54 1.54 1.54 0.29 0.29 0.29 0.29 -0.29 -0.29 -0.29 -0.29 -0.53 -0.53 -0.529
Debt/Assets 0.50 0.50 0.51 0.51 0.51 0.51 0.51 0.51 0.51 0.51 0.48 0.48 0.48 0.48 0.35 0.35 0.35 0.35 0.13 0.13 0.132
Debt/EBITDA -13.71 -5.26 -22.02 -4.40 -8.77 3.78 5.28 4.14 5.30 4.10 2.42 2.79 3.32 2.29 1.54 1.36 1.17 1.48 0.54 0.65 0.652
Net Debt/EBITDA -3.12 -1.20 -6.52 -1.30 -2.60 1.12 1.53 1.20 1.54 1.19 0.34 0.39 0.46 0.32 -0.56 -0.49 -0.42 -0.54 -1.29 -1.58 -1.576
Interest Coverage -1.45 -2.51 -1.24 -3.05 -2.05 1.93 1.04 1.44 0.86 1.29 2.59 2.12 1.64 2.82 2.94 3.84 5.34 4.81 6.40 6.40 6.401
Equity Multiplier -41.04 -41.04 -92.63 -92.63 -92.63 -92.63 10.28 10.28 10.28 10.28 4.31 4.31 4.31 4.31 2.32 2.32 2.32 2.32 1.66 1.66 1.660
Cash Ratio snapshot only 1.200
Debt Service Coverage snapshot only 8.457
Cash to Debt snapshot only 3.417
FCF to Debt snapshot only 1.878
Defensive Interval snapshot only 395.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 1.06 1.05 1.08 0.85 0.88 0.92 1.02 1.05 1.03 1.02 1.04 1.00 0.97 1.08 1.04 1.05 1.07 0.96 1.06 1.06 1.058
Inventory Turnover 18.84 18.94 12.06 8.52 9.08 9.50 9.47 9.88 9.35 9.49 10.80 10.37 10.17 12.89 8.15 8.13 8.34 6.19 8.17 8.15 8.150
Receivables Turnover 9.36 9.20 8.72 6.91 7.12 7.50 6.26 6.45 6.32 6.29 5.34 5.14 4.97 5.52 5.77 5.83 5.96 5.31 5.33 5.30 5.304
Payables Turnover 3.99 4.01 5.48 3.87 4.12 4.31 6.26 6.53 6.18 6.27 9.41 9.03 8.85 11.22 10.39 10.36 10.63 7.90 11.01 10.98 10.984
DSO 39 40 42 53 51 49 58 57 58 58 68 71 73 66 63 63 61 69 68 69 68.8 days
DIO 19 19 30 43 40 38 39 37 39 38 34 35 36 28 45 45 44 59 45 45 44.8 days
DPO 91 91 67 94 89 85 58 56 59 58 39 40 41 33 35 35 34 46 33 33 33.2 days
Cash Conversion Cycle -33 -32 6 1 3 3 39 38 38 38 63 66 68 62 73 72 71 81 80 80 80.4 days
Fixed Asset Turnover snapshot only 40.859
Operating Cycle snapshot only 113.6 days
Cash Velocity snapshot only 2.329
Capital Intensity snapshot only 0.952
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 5.7% 6.3% 12.5% -26.2% -18.8% -13.0% -9.9% 17.1% 11.2% 5.2% 3.3% -3.6% -4.8% 6.3% -2.2% 2.7% 8.6% -13.0% -0.9% -2.4% -2.38%
Net Income 15.9% 14.2% 51.6% -84.5% 1.6% 1.2% 1.0% 1.1% 92.9% -62.2% 10794.5% 2.2% 4.6% 5.3% 40.2% 1.5% 4.6% 59.1% 2.8% -35.9% -35.94%
EPS 16.9% 16.5% 53.0% -78.8% 12.2% 1.2% 1.0% 1.1% 93.2% -64.0% 10294.3% 2.1% 4.5% 5.1% 36.3% 1.4% 4.4% 53.6% -1.5% -37.1% -37.13%
FCF 2.2% 36.4% 3.2% -2.2% -22.8% -3.8% -2.1% 73.6% 1.3% 1.2% 1.6% 7.1% 1.9% 6.3% 1.7% -12.1% 33.0% 27.3% 7.4% 72.0% 71.96%
EBITDA 57.3% 31.7% 85.2% -32.4% -50.7% 2.3% 5.1% 2.0% 2.6% -9.7% 1.1% 44.6% 55.8% 74.6% 4.5% 36.8% 88.6% 3.0% 11.0% -19.9% -19.91%
Op. Income 34.6% 40.7% 4.5% -13.5% -7.4% 40.4% 1.8% 1.6% 2.0% 3.8% 37.6% -9.9% -12.7% 16.3% -5.1% 43.4% 1.4% 3.6% 20.5% -20.8% -20.84%
OCF Growth snapshot only 71.35%
Asset Growth snapshot only 1.39%
Equity Growth snapshot only 41.48%
Debt Growth snapshot only -61.47%
Shares Change snapshot only 1.88%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 20.7% 7.5% 0.3% -10.9% -10.3% -8.1% -5.7% 1.6% -1.5% -0.9% 1.5% -5.9% -4.9% -0.9% -3.1% 5.1% 4.8% -0.9% 0.0% -1.1% -1.13%
Revenue 5Y 1.0% 52.5% 20.1% 9.7% 2.6% -1.3% -4.4% -5.2% -2.8% -3.3% 0.7% -0.3% -2.1% 0.3% -3.5% -3.54%
EPS 3Y 49.9% 23.0% 67.6% 67.57%
EPS 5Y
Net Income 3Y 55.5% 24.0% 71.8% 71.83%
Net Income 5Y
EBITDA 3Y 17.5% 35.1% 16.6% 16.58%
EBITDA 5Y
Gross Profit 3Y 15.7% 2.7% -4.3% -14.3% -14.0% -11.7% -9.8% -1.6% -4.7% -4.0% -2.3% -7.8% -5.9% -3.5% -4.3% 2.7% 2.7% -0.9% -0.5% -1.6% -1.61%
Gross Profit 5Y 1.1% 51.0% 16.7% 7.2% 0.1% -4.4% -7.6% -8.5% -7.1% -6.7% -2.0% -3.2% -3.7% -1.7% -4.4% -4.43%
Op. Income 3Y 86.6% 16.3% 0.8% 0.75%
Op. Income 5Y 49.1% 49.15%
FCF 3Y -15.3% 25.5% 1.7% 47.8% 23.5%
FCF 5Y 3.8% 3.9% 12.0% 3.2% 41.2% 24.5% 24.49%
OCF 3Y -20.2% 44.9% 2.3% 8.4% 41.9% 18.2% 23.5% 57.5% 57.54%
OCF 5Y 3.6% 3.9% 11.7% 3.0% 40.1% 1.2% 13.9% 13.89%
Assets 3Y 13.8% 13.8% -4.4% -4.4% -4.4% -4.4% -1.9% -1.9% -1.9% -1.9% -1.9% -1.9% -1.9% -1.9% -2.0% -2.0% -2.0% -2.0% -0.9% -0.9% -0.87%
Assets 5Y 0.4% 0.4% -2.2% -2.2% -2.2% -2.2% 6.1% 6.1% 6.1% 6.1% -2.3% -2.3% -2.3% -2.3% -1.9% -1.9% -1.9% -1.9% -2.4% -2.4% -2.40%
Equity 3Y 7.4% 7.4% 7.4% 7.4% 82.0% 82.0% 82.03%
Book Value 3Y 1.8% 1.0% 1.6% 0.9% 75.0% 77.5% 77.52%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.78 0.72 0.61 0.44 0.43 0.48 0.53 0.51 0.39 0.20 0.16 0.53 0.72 0.51 0.81 0.16 0.01 0.09 0.20 0.74 0.738
Earnings Stability 0.89 0.86 0.85 0.85 0.84 0.86 0.79 0.79 0.76 0.93 0.99 0.89 0.88 0.91 0.98 0.88 0.89 0.88 0.90 0.73 0.733
Margin Stability 0.94 0.93 0.93 0.94 0.93 0.93 0.94 0.94 0.94 0.94 0.93 0.93 0.93 0.92 0.92 0.94 0.94 0.93 0.95 0.97 0.971
Rev. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 0.00 0.50 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.94 0.50 0.50 0.99 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.50 0.84 0.50 0.50 0.50 0.99 0.86 0.856
Earnings Smoothness 0.10 0.00 0.00 0.00 0.67 0.15 0.00 0.54 0.97 0.56 0.562
ROE Trend 0.13 0.16 0.50 0.10 -0.13 -0.16 -0.163
Gross Margin Trend -0.10 -0.10 -0.10 -0.03 -0.03 -0.02 -0.03 -0.02 0.00 -0.00 -0.02 -0.03 -0.04 -0.07 -0.03 -0.02 -0.02 0.04 0.02 0.02 0.015
FCF Margin Trend -0.04 -0.02 0.06 -0.20 -0.17 -0.17 -0.12 -0.00 0.13 0.07 0.07 0.22 0.21 0.19 0.19 0.07 0.09 0.12 0.07 0.09 0.091
Sustainable Growth Rate 0.0% 50.2% 38.8% 57.5% 41.0% 23.2% 61.9% 41.6% 52.3% 66.6% 50.8% 28.0% 21.9% 21.92%
Internal Growth Rate 4.4% 0.0% 2.2% 1.7% 10.5% 7.3% 4.0% 11.4% 15.8% 20.7% 27.9% 20.0% 16.9% 12.8% 12.80%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.33 -0.42 -0.71 0.45 1.04 -2.94 -7913.50 2.85 -12.66 6.52 1.25 2.32 3.82 1.45 1.29 0.82 0.92 1.16 1.34 2.20 2.198
FCF/OCF 0.14 0.51 1.00 1.00 1.00 1.00 1.44 -0.42 0.37 0.19 0.53 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 2.198
OCF/EBITDA snapshot only 1.225
CapEx/Revenue 3.9% 4.0% 0.0% 0.0% 0.0% 0.0% 3.1% 8.3% 8.5% 8.6% 5.4% 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.1% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.001
Accruals Ratio -0.19 -0.29 -0.21 -0.11 0.01 0.16 0.07 -0.04 -0.15 -0.09 -0.02 -0.09 -0.11 -0.05 -0.04 0.03 0.02 -0.03 -0.05 -0.14 -0.136
Sloan Accruals snapshot only 0.090
Cash Flow Adequacy snapshot only 5360.600
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% 0.0% 0.0% -8.2% -7.7% -9.3% -6.5% -1.7% -1.5% -2.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.1% -0.2% -0.0% -0.0% -0.0% -0.04%
Total Shareholder Return -0.0% 0.0% 0.0% -8.2% -7.7% -9.3% -6.5% -1.7% -1.5% -2.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.1% -0.2% -0.0% -0.0% -0.0% -0.04%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.01 1.01 1.01 0.96 0.00 0.89 1.40 0.82 0.95 0.93 0.87 0.94 1.26 1.19 1.15 1.20 0.87 0.84 0.838
Interest Burden (EBT/EBIT) 1.70 1.40 1.81 1.33 1.49 0.48 0.04 0.30 -0.16 0.27 0.66 0.58 0.46 0.66 0.66 0.74 0.81 0.79 0.84 0.88 0.878
EBIT Margin -0.08 -0.14 -0.06 -0.18 -0.11 0.10 0.05 0.07 0.05 0.07 0.15 0.13 0.10 0.15 0.16 0.19 0.22 0.18 0.19 0.15 0.146
Asset Turnover 1.06 1.05 1.08 0.85 0.88 0.92 1.02 1.05 1.03 1.02 1.04 1.00 0.97 1.08 1.04 1.05 1.07 0.96 1.06 1.06 1.058
Equity Multiplier 41.62 41.62 -56.07 -56.07 -56.07 -56.07 23.41 23.41 23.41 23.41 6.03 6.03 6.03 6.03 3.05 3.05 3.05 3.05 1.93 1.93 1.931
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.87 $-1.18 $-0.71 $-1.16 $-0.76 $0.22 $0.00 $0.10 $-0.05 $0.08 $0.45 $0.32 $0.18 $0.47 $0.61 $0.76 $0.97 $0.73 $0.60 $0.48 $0.48
Book Value/Share $-0.15 $-0.15 $-0.06 $-0.06 $-0.05 $-0.05 $0.47 $0.46 $0.46 $0.45 $1.11 $1.11 $1.11 $1.09 $1.86 $1.85 $1.84 $1.81 $2.53 $2.56 $2.53
Tangible Book/Share $-1.98 $-1.96 $-1.67 $-1.62 $-1.51 $-1.50 $-1.07 $-1.04 $-1.04 $-1.02 $-0.15 $-0.15 $-0.15 $-0.15 $0.83 $0.82 $0.82 $0.80 $1.73 $1.75 $1.75
Revenue/Share $6.30 $6.13 $6.17 $4.76 $4.56 $4.78 $4.98 $4.98 $4.88 $4.79 $4.91 $4.70 $4.54 $4.95 $4.66 $4.66 $4.75 $4.16 $4.43 $4.47 $4.47
FCF/Share $0.04 $0.26 $0.50 $-0.52 $-0.79 $-0.64 $-0.50 $-0.12 $0.24 $0.10 $0.30 $0.74 $0.69 $0.68 $0.79 $0.62 $0.88 $0.84 $0.81 $1.05 $1.05
OCF/Share $0.29 $0.50 $0.50 $-0.52 $-0.79 $-0.64 $-0.35 $0.29 $0.65 $0.51 $0.56 $0.74 $0.69 $0.69 $0.79 $0.63 $0.88 $0.84 $0.81 $1.05 $1.05
Cash/Share $2.31 $2.29 $2.00 $1.95 $1.81 $1.80 $1.77 $1.72 $1.72 $1.70 $2.00 $1.99 $1.99 $1.95 $2.04 $2.02 $2.01 $1.98 $1.89 $1.92 $2.00
EBITDA/Share $-0.22 $-0.56 $-0.13 $-0.63 $-0.29 $0.68 $0.47 $0.59 $0.46 $0.58 $0.96 $0.83 $0.69 $0.99 $0.97 $1.10 $1.26 $0.98 $1.04 $0.86 $0.86
Debt/Share $2.99 $2.96 $2.84 $2.76 $2.57 $2.56 $2.49 $2.42 $2.42 $2.39 $2.32 $2.31 $2.31 $2.27 $1.50 $1.48 $1.48 $1.45 $0.55 $0.56 $0.56
Net Debt/Share $0.68 $0.68 $0.84 $0.82 $0.76 $0.76 $0.72 $0.70 $0.70 $0.69 $0.32 $0.32 $0.32 $0.32 $-0.54 $-0.54 $-0.54 $-0.53 $-1.34 $-1.36 $-1.36
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.034
Altman Z-Prime snapshot only -11.881
Piotroski F-Score 5 5 4 2 0 3 3 6 6 5 6 6 5 6 6 5 4 5 6 5 5
Beneish M-Score -3.24 -3.61 -3.26 -2.10 -2.15 -1.44 -1.82 -2.37 -2.91 -2.58 -2.40 -2.78 -2.88 -2.36 -3.11 -2.63 -2.63 -3.13 -2.18 -2.57 -2.568
Ohlson O-Score snapshot only -8.530
ROIC (Greenblatt) snapshot only 38.09%
Net-Net WC snapshot only $1.51
EVA snapshot only $18582675.25
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 20.00 20.00 20.00 20.00 20.00 20.00 17.63 19.61 19.09 21.07 35.94 38.64 32.38 38.59 47.50 48.70 55.18 51.16 57.40 56.81 56.805
Credit Grade snapshot only 9
Credit Trend snapshot only 8.105
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 51
Sector Credit Rank snapshot only 49

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms